在细胞癌中血清miRNA的评估:系统性审查

Giovanni Cochetti1, Liliana Guadagni1, Alessio Paladini1

  • 1Urology Clinic, Department of Medicine and Surgery, Santa Maria della Misericordia Hospital, University of Perugia, 06129 Perugia, Italy.

Cancers
|March 13, 2025
PubMed
概括

血清微RNAs (miRNAs) 显示出诊断细胞癌 (RCC) 的前景. 这次审查确定了像miR-210这样在RCC患者中发生变化的特定miRNA,这表明了潜在的非侵入性诊断标记.